Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Hassoun, D. Lair, V. Forest, M.A. Cheminant, C. Sagan, J. Chesné, K. Botturi-Cavaillès, D. Reboulleau, P. Lemarchand, A. Magnan (Nantes, France). Immune modulation by mesenchymal stem cells in a mouse model of house dust mite allergic asthma. Eur Respir J 2012; 40: Suppl. 56, 2364

Member's Comments

No comment yet.

Related content which might interest you: PP114 – Mesenchymal stromal cells reduce house dust mite induced allergic airway inflammation in a humanised MIF expressing mouse model Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2021 - Mesenchymal stromal cells reduce house dust mite induced allergic airway inflammation in a humanised MIF expressing mouse model Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 YS2: Role of Th9 cells in allergic airway inflammation induced by house dust mite Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 LATE-BREAKING ABSTRACT: IRF3 is required for the induction of allergic airway inflammation by lung dendritic cells in a mouse model of house dust mite-induced atopic asthma Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 A novel house dust mite-induced asthma model in guinea pigs driven by mast cells Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Inflammatory and remodeling events in a murine model of asthma according to chronic exposure to house dust mite Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007 Local lung house dust mite (HDM) challenges induce cell necrosis in mouse experimental asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Calcaratarin D attenuates house dust mite-induced allergic asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 The effect of BCG treatment on the remodelling in the house dust mite induced allergic asthma in mice Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005 Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 The association of adult bronchial responsiveness with IgE sensitisation and exposure to cat and house dust mite allergen Source: Eur Respir J 2006; 28: Suppl. 50, 145s Year: 2006 Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 Poly:IC causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund‘s complete adjuvant Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Correlation between nasal eosinophilic inflammation and bronchial reactivity to methacholine in allergic children sensitized to house dust mites (HDM) Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002 A house dust mite-induced asthma model in transcutaneously sensitized mice Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Sensitisation to house dust mite: its association with bronchial hyperresponsiveness and lung function in asthmatic children Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Models to mimic allergic asthma using house dust mite or Aspergillus fumigatus in mice: advantages and disadvantages Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005 Safety of subcutaneous immunotherapy with standardized extracts of house dust mite in allergic asthmatic subjects Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 The effect of montelukast during allergen sensitization period in house dust mite mouse model Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017